🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

Ibex Ltd CIO sells shares worth over $200k

Published 17/09/2024, 21:26
© Reuters.
IBEX
-

James Dominic Ferrato, the Chief Information Officer of IBEX Ltd (NASDAQ:IBEX), has recently made significant transactions in the company's stock, according to the latest filings. On February 29, 2024, Ferrato sold 13,000 shares of IBEX Ltd at an average price of $16.01 per share, totaling over $208,130.


The transactions come as part of Ferrato's financial activities involving both the acquisition and disposal of IBEX Ltd's common shares. On the same day, he acquired 13,000 shares at a price of $12.75 each, amounting to a total of $165,750. These buy transactions are related to the exercise of stock options that are fully vested and exercisable, as indicated in the footnotes of the filing.


Investors often monitor insider transactions as they provide insights into how executives and directors view the financial health and prospects of their company. Ferrato's role as CIO places him in a position with substantial knowledge of the company's operations and potential, making his trading activities of particular interest to current and potential shareholders.


Following the reported transactions, Ferrato's ownership in the company stands at 12,356 common shares. It's important to note that the sales and acquisitions of shares by company insiders are routine and can occur for various reasons, including portfolio diversification or financial planning.


IBEX Ltd, with its standard industrial classification in computer processing and data preparation services, continues to navigate the tech industry landscape, with its executives' stock transactions being a regular part of corporate governance and financial management.


In other recent news, IBEX Ltd. reported a transformative year with a record increase in EPS to $2.10 and a rise in free cash flow to $27 million, despite a slight annual revenue decrease to $509 million. However, the company's Q4 revenue indicated a year-over-year increase, suggesting a return to growth. Financial services firm Baird increased its price target for IBEX shares to $23.00, maintaining an Outperform rating. The firm expressed a positive outlook on IBEX's potential, citing signs of industry stabilization and the company's aspiration to achieve 5-7% revenue growth and 15% EBITDA margins over time.


RBC Capital Markets also raised its price target for IBEX from $18 to $20, maintaining a Sector Perform rating, following the company's announcement of a return to revenue growth. The revised stock price target reflects RBC's confidence in IBEX's strategic direction, which includes a focus on more profitable service areas and advanced technologies. Meanwhile, Baird reaffirmed its Outperform rating for IBEX following the company's strong financial results for the fourth quarter.


As these recent developments unfold, IBEX is entering fiscal year 2025 with a positive outlook, expecting revenue between $510 million and $525 million and adjusted EBITDA of $67 million to $69 million. Both Baird and RBC Capital Markets' analyses and adjustments are based on the company's recent performance and projected growth.


InvestingPro Insights


IBEX Ltd (NASDAQ:IBEX) has been demonstrating compelling financial metrics and market performance that could be of interest to investors following recent insider transactions. As of the last twelve months leading up to Q4 2024, IBEX has maintained a healthy market capitalization of $323.63 million and has shown noteworthy returns, with a 46.73% increase in the stock price over the past year. The company's P/E ratio stands at a modest 10.13, which is below the adjusted figure of 8.89 for the same period. This suggests that the stock may be trading at a low earnings multiple, which is further supported by an InvestingPro Tip highlighting the company's low P/E ratio relative to near-term earnings growth.


IBEX's financial stability is underscored by its ability to cover its interest payments with cash flows and the fact that its liquid assets exceed short-term obligations. This is a sign of the company's strong financial health and risk management. Additionally, the company has been generating solid returns for investors, with a significant return over the last week of 18.69%, and an impressive three-month price total return of 23.85%. These figures align with an InvestingPro Tip that points out the strong returns over the last week, month, and three months, indicating sustained positive momentum in the stock's performance.


Investors may also find it encouraging that IBEX operates with a moderate level of debt and has been profitable over the last twelve months. The company's share performance has been robust, with the price reaching 92.8% of its 52-week high. This could potentially signal confidence in the company's future prospects and aligns with another InvestingPro Tip that notes the large price uptick over the last six months.


For those seeking further insights, there are additional InvestingPro Tips available on the company's profile, providing a more comprehensive analysis of IBEX Ltd's financial health and market performance. Interested readers can find these valuable tips and metrics by visiting the InvestingPro platform.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.